STERIS STE Ratios & Valuation
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 176.8%+3.0pp | 176.5%+3.7pp | 175.9%+2.8pp | 174.6%+1.0pp | 173.7%-0.3pp | |
| Operating margin | 69.4%+5.7pp | 66.8%+2.6pp | 65.7%-9.6pp | 64.6%-22.2pp | 63.7%-25.2pp | |
| Net margin | 49%+13.3pp | 47.1%+15.2pp | 43.6%+9.1pp | 39.7%+1.9pp | 35.7%+3.0pp | |
| EBITDA margin | 103.2%+2.0pp | 101.1%-2.9pp | 100.7%-16.8pp | 100.5%-31.0pp | 101.3%-33.8pp | |
| Free cash flow margin | 65.3%+13.0pp | 63.2%+13.2pp | 61.3%+13.4pp | 57.3%+11.0pp | 52.3%+6.8pp | |
| Returns | ||||||
| Return on equity | 41.6%+11.6pp | 39.8%+13.2pp | 36.6%+8.2pp | 33.3%+2.5pp | 30%+3.7pp | |
| Return on assets | 27.3%+9.3pp | 25.6%+9.9pp | 23.1%+6.7pp | 20.5%+3.1pp | 18%+3.3pp | |
| Return on invested capital | 34.9%+5.3pp | 32.7%+3.5pp | 31.4%-2.3pp | 30.3%-7.8pp | 29.5%-8.5pp | |
| Efficiency | ||||||
| Asset turnover | 2.2×+0.2× | 2.2×+0.2× | 2.1×+0.2× | 2.1×+0.2× | 2×+0.2× | |
| Inventory turnover | 19.7×+2.7× | 19.2×+2.5× | 18.3×+2.0× | 17.6×+1.6× | 17×+1.3× | |
| Liquidity | ||||||
| Current ratio | 9.2×+0.3× | 9×-0.9× | 8.7×-1.6× | 8.7×-1.6× | 8.8×-1.5× | |
| Quick ratio | 6.4×+0.6× | 6.3×-0.5× | 5.9×-0.9× | 5.9×-1.0× | 5.8×-1.0× | |
| Cash ratio | 1.5×+0.7× | 1.3×+0.4× | 1×+0.1× | 0.9×-0.1× | 0.8×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1.1×-0.3× | 1.2×-0.5× | 1.3×-0.6× | 1.3×-0.7× | 1.5×-0.7× | |
| Debt-to-assets | 0.7×-0.2× | 0.8×-0.2× | 0.8×-0.2× | 0.9×-0.3× | 0.9×-0.3× | |
| Net debt / EBITDA | 4.3×-2.1× | 4.9×-2.3× | 5.5×-1.8× | 6×-1.4× | 6.4×-1.3× | |
| Interest coverage | 61.4×+30.6× | 53.3×+26.7× | 45.7×+17.5× | 38×+6.3× | 30.9×-2.1× | |
| Valuation | ||||||
| Market capitalization | $94.51B+7.1% | $95.09B+7.8% | $90.5B+1.0% | $90.11B+3.2% | $88.24B+0.5% | |
| Enterprise value | $100.94B+4.1% | $102.03B+4.1% | $98.09B-2.4% | $98.26B-1.1% | $96.96B-3.5% | |
| Price / earnings | 134.7×-54.3× | 143.3×-68.3× | 151.5×-54.9× | 171.2×-19.5× | 189×-134× | |
| Price / sales | 16.4×-0.1× | 16.9×+0.1× | 16.3×-1.0× | 16.6×-0.7× | 16.5×-1.4× | |
| Price / book | 13.4×-0.2× | 13.7×0.0× | 13.4×-0.6× | 13.6×-0.3× | 13.6×-0.4× | |
| EV / EBITDA | 68.1×-3.5× | 71.6×+0.1× | 70.4×+2.5× | 71.9×+10.1× | 71.6×+9.2× | |
| EV / sales | 17.5×-0.6× | 18.1×-0.5× | 17.7×-1.7× | 18.1×-1.6× | 18.1×-2.4× | |
| Free cash flow yield | 16%+3.2pp | 15%+2.9pp | 15%+3.9pp | 13.9%+3.2pp | 12.8%+2.6pp | |
| Earnings yield | 12%+3.3pp | 11.2%+3.5pp | 10.6%+2.7pp | 9.6%+0.9pp | 8.7%+1.3pp | |
| Dividend yield | 4%+0.1pp | 3.8%0.0pp | 3.9%+0.3pp | 3.9%+0.2pp | 3.9%+0.3pp | |
| PEG ratio | 2.9×— | 2.5×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are STERIS's profit margins?
- STERIS (STE) runs a 44.2% gross margin and a 18.6% operating margin, with a 13.2% net margin.
- Where do STERIS's ratios come from?
- Every ratio is computed from STERIS's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
